S. Skriver

Patterns in detection of recurrence among patients treated for breast cancer

C. Johansen, J. Overgaard, M. Andersson, 2020, Breast Cancer Research and Treatment.

Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients

A. Laenkholm, M. Jensen, B. Ejlertsen, 2020, Breast Cancer Research and Treatment.

Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG)

A. Laenkholm, B. Rasmussen, M. Jensen, 2018, Acta oncologica.

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

A. Laenkholm, M. Jensen, B. Ejlertsen, 2020, Breast Cancer Research.

Abstract P4-10-18: Changes in tumour infiltrating lymphocytes during neoadjuvant endocrine therapy and possible clinical implications for guiding therapy

A. Laenkholm, M. Jensen, B. Ejlertsen, 2020 .